Fundz

Tff Pharmaceuticals Receives Additional Funding From Leidos To Advance Next-Generation Personalized Protective Biosystems Under The Darpa Ppb Program

PRIVATEMay 01, 2023

Round Type

Funding Round

Fort WorthHealthcare

Description

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that Leidos, a leading Fortune 500 information technology, engineering and science solutions and services leader, has awarded the Company additional funding under the DARPA Personalized Protective Biosystems (PPB) program to develop next-generation countermeasures for military and healthcare personnel.

Quick answer

TFF Pharmaceuticals, Inc. raised an undisclosed amount in a Funding Round round, dated May 1, 2023. TFF Pharmaceuticals, Inc. is based in Fort Worth, Texas, United States.

How much did TFF Pharmaceuticals, Inc. raise?
TFF Pharmaceuticals, Inc. raised an undisclosed amount in a Funding Round round on May 1, 2023.
What does TFF Pharmaceuticals, Inc. do?
TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaging patented rapid freezing technology to develop and transform medicines into potent dry powder formulations for better efficacy, safety, and..
Where is TFF Pharmaceuticals, Inc. based and how big is it?
TFF Pharmaceuticals, Inc. is based in Fort Worth, Texas, United States.
Who are the decision-makers at TFF Pharmaceuticals, Inc?
Fundz holds 1 contact at TFF Pharmaceuticals, Inc., including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as TFF Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Hummingbird Healthcare raised $1.2M (Seed) on May 9, 2023.
  • Beyond Air raised $40M (Debt Financing) on June 15, 2023.
  • Sword Bio raised $50K (Pre-Seed) on June 15, 2023.
  • Octave raised $52M (Series C) on June 15, 2023.
  • Nue Life Health raised $1.9M (Seed) on June 15, 2023.
  • Beyond Air raised $1.4M (Seed) on June 15, 2023.

Who to call at TFF Pharmaceuticals, Inc., and when

A new round usually means TFF Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day TFF Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TFF Pharmaceuticals, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TFF Pharmaceuticals, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TFF Pharmaceuticals, Inc.

Location

2600 VIA FORTUNA

Fort Worth, Texas, United States

About

TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaging patented rapid freezing technology to develop and transform medicines into potent dry powder formulations for better efficacy, safety, and stability. The company’s versatile Thin Film Freezing (TFF) technology platform has broad applicability to convert most any drug, including vaccines, small and large molecules, and biologics, into an elegant dry powder highly advantageous for inhalation, with improved absorption so drugs can also be delivered to the eyes, nose and topically to the skin. TFF has two lead drug candidates in the clinic: TFF VORI (Voriconazole Inhalation Powder) and TFF TAC (Tacrolimus Inhalation Powder). The Company continues collaborations with a broad array of pharmaceutical companies, academic institutions, and government partners to revolutionize healthcare around the globe. The TFF Platform is protected by 120+ patents issued or pending in the U.S. and internationally. To learn more about TFF Pharmaceuticals and its product candidates, visit the Company’s website at https://tffpharma.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TFF Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsKIRK C., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for TFF Pharmaceuticals, Inc.'s next move

See what Strategic adds

TFF Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.